Dr. Nataliya Karyakina brings extensive expertise in toxicology and risk assessment to RSI. With a Ph.D. in Toxicology and experience at the McLaughlin Centre for Population Health Risk Assessment, she specializes in evaluating health risks from exposure to various toxic agents. Her research spans essential and toxic metals, pharmaceuticals, and nanomaterials. She has contributed to projects on chemical classification and labeling, as well as health-based regulatory guidance. Currently, she focuses on the health effects of engineered nanoalumina and diagnostic criteria for occupational manganism.

Dr. Patricia Larkin's career is dedicated to policy and regulatory assessments, focusing on the intersection of social determinants of health and health equity. Her expertise lies in managing human health and environmental risks, particularly in energy, water resources, and climate change. Patricia's research explores Canadian innovation in energy regulatory decision-making and its impact on risk management. She has led interdisciplinary international research projects, addressing risk management in public decision-making and environmental issues like carbon capture and storage. As Chair of the Applied Risk Management Specialty Group of the Society for Risk Analysis, she continues to contribute to this field.

John Lark is a globally recognized expert in risk management, with a distinguished career spanning leadership roles in research, committee chairing, and board-level facilitation. He collaborates with international bodies, including the OECD, US EPA, and ISO. Mr. Lark's expertise extends to speaking engagements at prominent conferences worldwide. He holds the CPRM certification and actively contributes to ISO committees. His extensive board experience includes chairing two not-for-profit boards and participating in major charities. He earned the ICD.D designation through the Director's Education Program. Mr. Lark authored the international ISO Guide for implementing ISO 31000:2009.

For her work at RSI, Anne has built on her previous experience and academic research through work on communication on nuclear power and nuclear waste disposal; developing communication strategies and messaging on health risk issues; and...

Margaret Wilson holds a BSc, BEd, and MSc in Molecular Biology, with post-graduate certificates in Population Health Risk Assessment and Management. She has worked extensively in health risk research, from BSE risk management to foodborne hazards. Currently at RSI, her focus includes risk prioritization and addressing challenges related to climate change. Margaret's multidisciplinary background equips her to tackle complex risk issues effectively.

Paul Stanish holds a B.Sc. in Chemistry from Carleton University and a Ph.D. in Chemistry and Nanotechnology from the University of Waterloo. His doctoral research focused on energy movement in semiconducting oxides. Paul has experience in analytical chemistry and has developed Android applications for risk management in options trading. He joined Risk Sciences International in 2021, focusing on leveraging emerging tools to modernize client understanding of risk and streamline data culture.

Martin LeBlanc specializes in business development at RSI, focusing on client needs across various sectors including health, nuclear, and aerospace. With a background in electrical/mechanical technology and sales, he excels in assembling project teams and navigating complex procurement processes. He is adept at contract negotiation, proposal development, and is well-versed in Government of Canada procurement vehicles. Martin is also experienced in international projects and adapts quickly to new procurement processes.

Don Mattison's career is an amalgamation of medicine, science, and public service. He started with a Bachelor's degree in Chemistry and Mathematics, followed by a Master's from MIT in Chemistry. He then pivoted to medicine, obtaining an MD from Columbia University and focusing on pharmacology and toxicology in reproductive health during his residencies. Mattison has held several prestigious appointments, including Dean of the University of Pittsburgh's Graduate School of Public Health and Chief Medical Officer at Risk Sciences International. Throughout his career, he obtained medical licenses in six U.S. states and served in the U.S. Public Health Service, retiring with the rank of Captain. Most recently, he became a Distinguished Professor of Epidemiology at the University of South Carolina.

Greg Paoli earned both his Bachelor's and Master's degrees from the University of Waterloo, specializing in engineering and systems design. His early career involved diverse research projects at the University of Waterloo's Institute for Risk Research. Greg later founded Decisionalysis Risk Consultants in 1997 and co-founded Risk Sciences International in 2006. He has served on multiple high-profile committees, including those under the U.S. National Academy of Sciences. As CEO of Risk Sciences International, Greg focuses on risk-based regulatory transformations and has developed enabling technologies like FDA-iRISK. His work spans various sectors, from food and chemical safety to public health, and he continues to contribute to the advancement of risk-based decision-making methodologies.

Jennifer Go holds a BHSc in Health Sciences and an MSc in Epidemiology, both from the University of Ottawa. Her academic work has spanned epigenetics, mental illness, and environmental exposures. Joining Risk Sciences International in 2017 as a Risk Analyst, she specializes in epidemiology. Jennifer's skill set includes systematic reviews, data manipulation, and statistical modeling. She has worked on diverse projects, ranging from pharmacoeconomic evaluations to analyses involving large datasets and electronic health records.